Oncology & Cancer

High-risk clinic for melanoma surveillance is scalable

(HealthDay)—A structured surveillance program for high-risk melanoma patients can be scaled and successfully replicated even in a primary care skin cancer clinic, according to a study published online March 17 in JAMA Dermatology.

Oncology & Cancer

Why some melanoma patients do not respond to immunotherapy

By harnessing the immune system against cancer, immunotherapies have revolutionized the way some types of cancer are treated. But most patients—across cancer types—do not respond, and in most cases, scientists are at ...

Medical research

New test to help fight deadly melanoma

Researchers from QIMR Berghofer Medical Research Institute have developed a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy.

Oncology & Cancer

­­Algorithm that performs as accurately as dermatologists

A study has now been presented that boosts the evidence for using AI solutions in skin cancer diagnostics. With an algorithm they devised themselves, scientists at the University of Gothenburg show the capacity of technology ...

page 30 from 40